Company Encyclopedia
View More
name
Forian
FORA.US
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company’s subscription and services-based solutions cover the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries.
72.77 B
FORA.USMarket value -Rank by Market Cap -/-

Financial Score

21/11/2025 Update
B
Health Care TechnologyIndustry
Industry Ranking9/43
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-2.94%D
    • Profit Margin-3.03%D
    • Gross Margin51.64%B
  • Growth ScoreB
    • Revenue YoY37.47%A
    • Net Profit YoY55.59%B
    • Total Assets YoY-28.27%E
    • Net Assets YoY15.56%A
  • Cash ScoreC
    • Cash Flow Margin-3296.70%E
    • OCF YoY37.47%A
  • Operating ScoreB
    • Turnover0.57B
  • Debt ScoreB
    • Gearing Ratio24.66%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Forian Inc. reports third quarter revenue of $7.76 million and net loss of $151,220

    Forian Inc. reported Q3 2025 revenue of $7.8 million, up 66% from $4.7 million in Q3 2024. Net loss improved to $151,200 from $204,900. Net loss per share was $0.00, compared to $0.01. Adjusted EBITDA rose 153% to $470,600. Business developments included expanded health services partnerships and new financial analytics offerings. Forian expects full-year revenue and adjusted EBITDA at the higher end of previous ranges. Disclaimer: AI-generated content by PUBT, not financial advice.

    Reuters·
    US
    FORA
    +0.47%
    Reuters·
    US
    FORA
    +0.47%

    Forian Inc expected to post earnings of 1 cent a share - Earnings Preview

    Forian Inc is anticipated to report a 55% increase in quarterly revenue, reaching $7.264 million for the period ending September 30, 2025. The earnings estimate stands at 1 cent per share, with a "buy" rating from analysts. The median 12-month price target is $5.00, reflecting a potential upside of 56.6% from the last closing price of $2.17. Results are expected on November 11.

    Reuters·
    US
    FORA
    +0.47%
    Reuters·
    US
    FORA
    +0.47%

    Forian Inc. to Release Third Quarter 2025 Results

    Forian Inc. will announce its third quarter 2025 results on November 14, 2025. The results will be shared via a press release before a conference call and webcast, which will be available live. A replay of the call and the earnings release will also be accessible.

    Reuters·
    US
    FORA
    +0.47%
    Reuters·
    US
    FORA
    +0.47%

    Forian Inc. Files Initial Statement of Beneficial Ownership for General Counsel Caroline Strickland McGrail

    Forian Inc. has filed an initial statement of beneficial ownership (Form 3) with the SEC, naming Caroline Strickland McGrail as the beneficial owner and General Counsel. The filing is accessible through the SEC's EDGAR system. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.

    Reuters·
    US
    FORA
    +0.47%
    Reuters·
    US
    FORA
    +0.47%

    Forian (NASDAQ:FORA) Trading 2.6% Higher - Here's What Happened

    Forian Inc. (NASDAQ:FORA) shares rose 2.6% during mid-day trading, reaching a high of $2.39 before closing at $2.37. Trading volume increased by 73% compared to the average, with 44,780 shares exchanged. The company has a market cap of $73.74 million and a P/E ratio of -26.33. Forian provides data management and analytics solutions for the healthcare industry. Despite a Buy rating, analysts suggest other stocks may be better investment options.

    Market Beat·
    US
    FORA
    +0.47%
    Market Beat·
    US
    FORA
    +0.47%